Literature DB >> 30314718

Competing risks in survival data analysis.

Almut Dutz1, Steffen Löck2.   

Abstract

Clinical trials and retrospective studies in the field of radiation oncology often consider time-to-event data as their primary endpoint. Such studies are susceptible to competing risks, i.e. competing events may preclude the occurrence of the event of interest or modify the chance that the primary endpoint occurs. Competing risks are frequently neglected and the event of interest is analysed with standard statistical methods. Here, we would like to create awareness of the problem and demonstrate different methods for survival data analysis in the presence of competing risks.
Copyright © 2018 Elsevier B.V. All rights reserved.

Keywords:  Competing risk; Cox regression; Survival data; Time-to-event data

Mesh:

Year:  2018        PMID: 30314718     DOI: 10.1016/j.radonc.2018.09.007

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  10 in total

1.  Stereotactic body radiotherapy for elderly patients (≥ 75 years) with early-stage non-small cell lung cancer.

Authors:  Zekai Shu; Baiqiang Dong; Lei Shi; Wei Shen; Qingqing Hang; Jin Wang; Yuanyuan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2020-02-24       Impact factor: 4.553

2.  Efficacy of Palliative Bladder Radiotherapy for Hematuria in Advanced Bladder Cancer Using Contemporary Radiotherapy Techniques.

Authors:  Jeremy Tey; Yu Yang Soon; Timothy Cheo; Kiat Huat Ooi; Francis Ho; Balamurugan Vellayappan; David Chia; Bee Choo Tai
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

Review 3.  Methodological evaluation of bias in observational COVID-19 studies on drug effectiveness.

Authors:  Oksana Martinuka; Maja von Cube; Martin Wolkewitz
Journal:  Clin Microbiol Infect       Date:  2021-04-01       Impact factor: 8.067

4.  Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy.

Authors:  Yi-Lun Chen; Chiao-Ling Tsai; Jason Chia-Hsien Cheng; Chun-Wei Wang; Shih-Hung Yang; Yu-Wen Tien; Sung-Hsin Kuo
Journal:  Front Oncol       Date:  2022-01-06       Impact factor: 6.244

5.  The Risk of Heart Disease-Related Death Among Anaplastic Astrocytoma Patients After Chemotherapy: A SEER Population-Based Analysis.

Authors:  Qi Lin; Jia-Hao Bao; Fei Xue; Jia-Jun Qin; Zhen Chen; Zhong-Rong Chen; Chao Li; Yi-Xuan Yan; Jin Fu; Zhao-Li Shen; Xian-Zhen Chen
Journal:  Front Oncol       Date:  2022-06-20       Impact factor: 5.738

6.  Analysis of using high-precision radiotherapy in the treatment of liver metastases regarding toxicity and survival.

Authors:  Theresa Voglhuber; Kerstin A Eitz; Markus Oechsner; Marco M E Vogel; Stephanie E Combs
Journal:  BMC Cancer       Date:  2021-07-06       Impact factor: 4.430

7.  Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.

Authors:  Theresa Voglhuber; Kerstin A Kessel; Markus Oechsner; Marco M E Vogel; Jürgen E Gschwend; Stephanie E Combs
Journal:  BMC Cancer       Date:  2020-06-08       Impact factor: 4.430

8.  Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study.

Authors:  Kosuke Ebina; Toru Hirano; Yuichi Maeda; Wataru Yamamoto; Motomu Hashimoto; Koichi Murata; Tohru Takeuchi; Hideyuki Shiba; Yonsu Son; Hideki Amuro; Akira Onishi; Kengo Akashi; Ryota Hara; Masaki Katayama; Keiichi Yamamoto; Atsushi Kumanogoh; Makoto Hirao
Journal:  Arthritis Res Ther       Date:  2020-06-15       Impact factor: 5.156

9.  Nongaussian Intravoxel Incoherent Motion Diffusion Weighted and Fast Exchange Regime Dynamic Contrast-Enhanced-MRI of Nasopharyngeal Carcinoma: Preliminary Study for Predicting Locoregional Failure.

Authors:  Ramesh Paudyal; Linda Chen; Jung Hun Oh; Kaveh Zakeri; Vaios Hatzoglou; C Jillian Tsai; Nancy Lee; Amita Shukla-Dave
Journal:  Cancers (Basel)       Date:  2021-03-06       Impact factor: 6.639

10.  Risk of primary liver cancer associated with gallstones and cholecystectomy: A competing risks analysis.

Authors:  Tong Liu; Sarah Tan Siyin; Nan Yao; Guoshuai Xu; Yi-Tsun Chen; Ning Duan; Wenqiang Li; Jun Qu; Siqing Liu
Journal:  Medicine (Baltimore)       Date:  2020-09-25       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.